Vote was nearly unanimous that the benefits of brexanolone outweigh risks, but only when used within a strict Risk Evaluation and Mitigation Strategies (REMS) program.
FDA Approvals …read more
Vote was nearly unanimous that the benefits of brexanolone outweigh risks, but only when used within a strict Risk Evaluation and Mitigation Strategies (REMS) program.
FDA Approvals …read more